Sign in

Celia Rouault

@celiarouault.bsky.social
76 followers 137 following 3 posts

Postdoc at Vindigni lab Washington University, Saint-Louis, MO Previous: PhD at Ginestier/Charafe lab, CRCM, France

PostsRepliesMedia
Reposted by Celia Rouault
CRCM @crcm.bsky.social · 24/04/2025
🕵️‍♀️ In this cancer Clue game: 🧬 Victim: CSCs 🔪 Weapon: Nifuroxazide 🎯 Mode: DNA crosslinks + STAT3 block 🧬 Scene: PARPi-resistant breast cancer From the Charafe/Ginestier team @CRCM 🔗 pubmed.ncbi.nlm.nih.gov/40038300/ ✍️ by @celiarouault.bsky.social 🔗 communities.springernature.com/posts/unveil...
032
Celia Rouault @celiarouault.bsky.social · 04/04/2025
Sometimes, conducting research feels like a police investigation! Discover the parallel between our article: Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer and police enquiry communities.springernature.com/posts/unveil... @cginestier.bsky.social
communities.springernature.com
Unveiling the Criminal Masterminds: Innovative Strategies in Cancer Research
030
Reposted by Celia Rouault
Anja Groth @groth-anja.bsky.social · 23/03/2025
Cells control the supply of new histones to chromatin by blocking histone chaperone function - see here how Codanin-1 sequesters 4 ASF1 molecules.
0247
Reposted by Celia Rouault
Lopes_Lab @lopeslab.bsky.social · 17/03/2025
Exciting seminar series from Genome integrity italian Network (GiiN), chaired by myself and Raffaella Di Micco! Short talks (2x30’), at convenient time for EU/USA attendees. Big shots and raising stars in an expanding field. See flyers + link to receive email alerts. Please repost to your network!👇
33834
Reposted by Celia Rouault
Eddy Pasquier 🧪🇫🇷🇦🇺 @eddpasquier.bsky.social · 04/03/2025
Glad to have contributed to this beautiful work led by @celiarouault.bsky.social & colleagues at @crcm.bsky.social just out in @naturecomms.bsky.social. Using drug repurposing, they unveiled the STAT3/FanA axis as a targetable vulnerability in breast cancer stem cells www.nature.com/articles/s41...
nature.com
Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer - Nature Communications
Targeting cancer stem cells (CSCs) has great potential in anti-cancer treatment. Here this group reports the role of antibiotic Nifuroxazide as a potent anti-CSC compound and fabricates it into an ant...
0135
Celia Rouault @celiarouault.bsky.social · 04/03/2025
I am thrilled to share my first paper published in @naturecomms.bsky.social, Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARPi in breast cancer @Christophe Ginestier @emmanuellecharafe.bsky.social I thanks all the collaborators and supporters rdcu.be/ecaao
182
Reposted by Celia Rouault
The Groth lab @grothlab.bsky.social · 19/02/2025
𝐇𝐨𝐰 𝐝𝐨 𝐜𝐞𝐥𝐥𝐬 𝐫𝐞𝐦𝐞𝐦𝐛𝐞𝐫 𝐰𝐡𝐨 𝐭𝐡𝐞𝐲 𝐚𝐫𝐞 𝐚𝐟𝐭𝐞𝐫 𝐃𝐍𝐀 𝐫𝐞𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧? Our new study “Disabling leading and lagging strand histone transmission results in parental histones loss and reduced cell plasticity and viability” is out in 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 𝘈𝘥𝘷𝘢𝘯𝘤𝘦𝘴. Led by @lleonie.bsky.social @biranalva.bsky.social 🧵 More below👇
tinyurl.com
Disabling leading and lagging strand histone transmission results in parental histones loss and reduced cell plasticity and viability
Losing parental histones during DNA replication fork passage challenges differentiation competence and cell viability.
511153
Reposted by Celia Rouault
Sumedha Agashe @sumedhaagashe.bsky.social · 31/01/2025
Check out our (@vindignilab.bsky.social) Spotlight article highlighting @durocher1.bsky.social group's discovery of synthetic lethal SMARCAL1-FANCM interaction, revealing a novel genetic buffering mechanism for genome stability at simple repeat regions during replication www.cell.com/trends/genet...
cell.com
Genetic buffering mechanisms in SNF2-family translocases
SNF2-family DNA translocases, a large family of ATPases, have poorly defined roles in genomic stability. In a recent study, Feng et al. identified a synthetic lethal interaction between the SNF2 trans...
1103